74
Participants
Start Date
September 20, 2020
Primary Completion Date
June 16, 2023
Study Completion Date
September 30, 2025
inhaled type I interferon
The interventional arm includes inhaled interferon (9.6 MUI x2/d for 48 hours, then 9.6 MUI x1/d for 8 to 16 days or discharge), in addition to standard care. In phase B, maximum treatment duration is 8 days.
WFI water nebulization
The interventional arm includes a WFI water nebulization comparator.
CH de Tourcoing, Tourcoing
CH de valenciennes, Valenciennes
CH Compiègne-Noyon, Compiègne
CH de l'Arrondissement de Montreuil-sur-mer, Rang-du-Fliers
CH d'Abbeville, Abbeville
CHU Amiens, Amiens
CH de Saint-Quentin, Saint-Quentin
CH TOURCOING
UNKNOWN
CH ARROND DE MONTREUIL
UNKNOWN
CH SAINT-QUENTIN
UNKNOWN
CH Compiègne
UNKNOWN
CH Abbeville
UNKNOWN
CH VALENCIENNES
UNKNOWN
Clinique Teissier
UNKNOWN
University Hospital, Toulouse
OTHER
University Hospital, Angers
OTHER_GOV
CHU CAEN
UNKNOWN
Nantes University Hospital
OTHER
Centre Hospitalier Universitaire, Amiens
OTHER